{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T18:57:59Z","timestamp":1793127479339,"version":"4.5.0"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.molmet.2021.101217","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T11:28:53Z","timestamp":1616498933000},"page":"101217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production"],"prefix":"10.1016","volume":"48","author":[{"given":"Parmanand","family":"Malvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radoslav","family":"Janostiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvindhan","family":"Nagarajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narendra","family":"Wajapeyee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"16","key":"10.1016\/j.molmet.2021.101217_bib1","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1101\/gad.1437206","article-title":"Malignant melanoma: genetics and therapeutics in the genomic era","volume":"20","author":"Chin","year":"2006","journal-title":"Genes & Development"},{"issue":"11","key":"10.1016\/j.molmet.2021.101217_bib2","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1101\/gad.191999.112","article-title":"Melanoma: from mutations to medicine","volume":"26","author":"Tsao","year":"2012","journal-title":"Genes & Development"},{"issue":"7","key":"10.1016\/j.molmet.2021.101217_bib3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.cell.2015.05.044","article-title":"Genomic classification of cutaneous melanoma","volume":"161","author":"Cancer Genome Atlas","year":"2015","journal-title":"Cell"},{"issue":"26","key":"10.1016\/j.molmet.2021.101217_bib4","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","article-title":"Improved survival with vemurafenib in melanoma with BRAF V600E mutation","volume":"364","author":"Chapman","year":"2011","journal-title":"New England Journal of Medicine"},{"issue":"20","key":"10.1016\/j.molmet.2021.101217_bib5","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa1406037","article-title":"Combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma","volume":"371","author":"Long","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.molmet.2021.101217_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/978-3-319-22539-5_10","article-title":"Targeted therapy for melanoma","volume":"167","author":"Wong","year":"2016","journal-title":"Cancer Treatment and Research"},{"issue":"7326","key":"10.1016\/j.molmet.2021.101217_bib7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nature09627","article-title":"COT drives resistance to RAF inhibition through MAP kinase pathway reactivation","volume":"468","author":"Johannessen","year":"2010","journal-title":"Nature"},{"issue":"7326","key":"10.1016\/j.molmet.2021.101217_bib8","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nature09626","article-title":"Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation","volume":"468","author":"Nazarian","year":"2010","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.molmet.2021.101217_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma","volume":"14","author":"Luke","year":"2017","journal-title":"Nature Reviews Clinical Oncology"},{"issue":"19","key":"10.1016\/j.molmet.2021.101217_bib10","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa1611299","article-title":"Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy","volume":"375","author":"Eggermont","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1016\/j.molmet.2021.101217_bib11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1365-2265.1994.tb03920.x","article-title":"The Diabetes Control and Complications Trial (DCCT): what every endocrinologist needs to know","volume":"40","author":"Hadden","year":"1994","journal-title":"Clinical Endocrinology"},{"issue":"9","key":"10.1016\/j.molmet.2021.101217_bib12","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1056\/NEJMoa1604958","article-title":"Mutations associated with acquired resistance to PD-1 blockade in melanoma","volume":"375","author":"Zaretsky","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1016\/j.molmet.2021.101217_bib13","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.molcel.2015.10.018","article-title":"Cancer's fuel choice: new flavors for a picky eater","volume":"60","author":"DeNicola","year":"2015","journal-title":"Molecular Cell"},{"issue":"10","key":"10.1016\/j.molmet.2021.101217_bib14","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1158\/2159-8290.CD-12-0345","article-title":"Cancer cell metabolism: one hallmark, many faces","volume":"2","author":"Cantor","year":"2012","journal-title":"Cancer Discovery"},{"issue":"1","key":"10.1016\/j.molmet.2021.101217_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","article-title":"The emerging hallmarks of cancer metabolism","volume":"23","author":"Pavlova","year":"2016","journal-title":"Cell Metabolism"},{"issue":"7","key":"10.1016\/j.molmet.2021.101217_bib16","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.trecan.2016.06.002","article-title":"Oncogene-directed alterations in cancer cell metabolism","volume":"2","author":"Nagarajan","year":"2016","journal-title":"Trends Cancer"},{"issue":"3","key":"10.1016\/j.molmet.2021.101217_bib17","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell"},{"issue":"4","key":"10.1016\/j.molmet.2021.101217_bib18","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2159-8290.CD-13-0440","article-title":"Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis","volume":"4","author":"Parmenter","year":"2014","journal-title":"Cancer Discovery"},{"issue":"6","key":"10.1016\/j.molmet.2021.101217_bib19","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.cellsig.2007.12.006","article-title":"The sphingolipid salvage pathway in ceramide metabolism and signaling","volume":"20","author":"Kitatani","year":"2008","journal-title":"Cellular Signalling"},{"issue":"5","key":"10.1016\/j.molmet.2021.101217_bib20","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1194\/jlr.M032375","article-title":"Acid ceramidase as a therapeutic target in metastatic prostate cancer","volume":"54","author":"Camacho","year":"2013","journal-title":"The Journal of Lipid Research"},{"issue":"15","key":"10.1016\/j.molmet.2021.101217_bib21","doi-asserted-by":"crossref","first-page":"24753","DOI":"10.18632\/oncotarget.15800","article-title":"Acid ceramidase is a novel drug target for pediatric brain tumors","volume":"8","author":"Doan","year":"2017","journal-title":"Oncotarget"},{"issue":"17","key":"10.1016\/j.molmet.2021.101217_bib22","doi-asserted-by":"crossref","first-page":"17647","DOI":"10.18632\/aging.103838","article-title":"Identification and prognostic value of metabolism-related genes in gastric cancer","volume":"12","author":"Wen","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.molmet.2021.101217_bib23","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.humpath.2018.01.004","article-title":"The value of detection of S100A8 and ASAH1 in predicting the chemotherapy response for breast cancer patients","volume":"74","author":"Li","year":"2018","journal-title":"Human Pathology"},{"issue":"9","key":"10.1016\/j.molmet.2021.101217_bib24","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1080\/00021369.1972.10860430","article-title":"A\u00a0convenient method for the quantitative determination of pipecolic acid","volume":"36","author":"Kandatsu","year":"1972","journal-title":"Agricultural & Biological Chemistry"},{"issue":"21","key":"10.1016\/j.molmet.2021.101217_bib25","doi-asserted-by":"crossref","first-page":"22284","DOI":"10.1074\/jbc.M312847200","article-title":"Imaging dynamic redox changes in mammalian cells with green fluorescent protein indicators","volume":"279","author":"Dooley","year":"2004","journal-title":"Journal of Biological Chemistry"},{"issue":"13","key":"10.1016\/j.molmet.2021.101217_bib26","doi-asserted-by":"crossref","first-page":"13044","DOI":"10.1074\/jbc.M312846200","article-title":"Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators","volume":"279","author":"Hanson","year":"2004","journal-title":"Journal of Biological Chemistry"},{"key":"10.1016\/j.molmet.2021.101217_bib27","series-title":"Methods in Molecular Biology","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/7651_2016_352","article-title":"Measuring redox status of melanoma cells","author":"Liu-Smith","year":"2016"},{"issue":"11","key":"10.1016\/j.molmet.2021.101217_bib28","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/j.freeradbiomed.2011.08.035","article-title":"Measuring E(GSH) and H2O2 with roGFP2-based redox probes","volume":"51","author":"Morgan","year":"2011","journal-title":"Free Radical Biology and Medicine"},{"issue":"1","key":"10.1016\/j.molmet.2021.101217_bib29","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.nbd.2011.08.022","article-title":"Genetically encoded redox sensor identifies the role of ROS in degenerative and mitochondrial disease pathogenesis","volume":"45","author":"Liu","year":"2012","journal-title":"Neurobiology of Disease"},{"issue":"2","key":"10.1016\/j.molmet.2021.101217_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2818.2008.02030.x","article-title":"Confocal imaging of glutathione redox potential in living plant cells","volume":"231","author":"Schwarzlander","year":"2008","journal-title":"Journal of Microscopy"},{"issue":"2","key":"10.1016\/j.molmet.2021.101217_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0003-2697(03)00388-9","article-title":"A\u00a0specific ceramide kinase assay to measure cellular levels of ceramide","volume":"320","author":"Bektas","year":"2003","journal-title":"Analytical Biochemistry"},{"issue":"3","key":"10.1016\/j.molmet.2021.101217_bib32","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.cell.2005.07.013","article-title":"Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice","volume":"122","author":"Ding","year":"2005","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.molmet.2021.101217_bib33","doi-asserted-by":"crossref","first-page":"6092","DOI":"10.1073\/pnas.0501564102","article-title":"The gene expression signatures of melanoma progression","volume":"102","author":"Haqq","year":"2005","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"20","key":"10.1016\/j.molmet.2021.101217_bib34","doi-asserted-by":"crossref","first-page":"7234","DOI":"10.1158\/1078-0432.CCR-05-0683","article-title":"Novel genes associated with malignant melanoma but not benign melanocytic lesions","volume":"11","author":"Talantov","year":"2005","journal-title":"Clinical Cancer Research"},{"key":"10.1016\/j.molmet.2021.101217_bib35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1755-8794-1-13","article-title":"The gene expression profiles of primary and metastatic melanoma yields a transition point of tumor progression and metastasis","volume":"1","author":"Riker","year":"2008","journal-title":"BMC Medical Genomics"},{"issue":"7391","key":"10.1016\/j.molmet.2021.101217_bib36","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1038\/nature11005","article-title":"Systematic identification of genomic markers of drug sensitivity in cancer cells","volume":"483","author":"Garnett","year":"2012","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.molmet.2021.101217_bib37","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1158\/0008-5472.CAN-09-3788","article-title":"Molecular target class is predictive of in\u00a0vitro response profile","volume":"70","author":"Greshock","year":"2010","journal-title":"Cancer Research"},{"issue":"38","key":"10.1016\/j.molmet.2021.101217_bib38","doi-asserted-by":"crossref","first-page":"35352","DOI":"10.1074\/jbc.M103066200","article-title":"Human acid ceramidase: processing, glycosylation, and lysosomal targeting","volume":"276","author":"Ferlinz","year":"2001","journal-title":"Journal of Biological Chemistry"},{"issue":"12","key":"10.1016\/j.molmet.2021.101217_bib39","doi-asserted-by":"crossref","first-page":"3481","DOI":"10.1016\/j.bbamcr.2013.06.026","article-title":"Anoikis molecular pathways and its role in cancer progression","volume":"1833","author":"Paoli","year":"2013","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"10.1016\/j.molmet.2021.101217_bib40","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0006-291X(88)90645-6","article-title":"Identification of L-pipecolate oxidase in human liver and its deficiency in the Zellweger syndrome","volume":"154","author":"Wanders","year":"1988","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"1","key":"10.1016\/j.molmet.2021.101217_bib41","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/0006-291X(89)91754-3","article-title":"L-pipecolate oxidase: a distinct peroxisomal enzyme in man","volume":"164","author":"Wanders","year":"1989","journal-title":"Biochemical and Biophysical Research Communications"},{"issue":"2","key":"10.1016\/j.molmet.2021.101217_bib42","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/ars.2014.5833","article-title":"Peroxisomal biogenesis in ischemic brain","volume":"22","author":"Young","year":"2015","journal-title":"Antioxid Redox Signal"},{"issue":"1","key":"10.1016\/j.molmet.2021.101217_bib43","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrc3398","article-title":"Ceramide-orchestrated signalling in cancer cells","volume":"13","author":"Morad","year":"2013","journal-title":"Nature Reviews Cancer"},{"issue":"8","key":"10.1016\/j.molmet.2021.101217_bib44","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1073\/pnas.95.8.4333","article-title":"ADD1\/SREBP1 activates PPARgamma through the production of endogenous ligand","volume":"95","author":"Kim","year":"1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"26","key":"10.1016\/j.molmet.2021.101217_bib45","doi-asserted-by":"crossref","first-page":"15712","DOI":"10.1073\/pnas.2536828100","article-title":"Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle","volume":"100","author":"He","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6294","key":"10.1016\/j.molmet.2021.101217_bib46","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/347645a0","article-title":"Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators","volume":"347","author":"Issemann","year":"1990","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.molmet.2021.101217_bib47","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/0092-8674(92)90031-7","article-title":"Control of the peroxisomal beta-oxidation pathway by a novel family of nuclear hormone receptors","volume":"68","author":"Dreyer","year":"1992","journal-title":"Cell"},{"issue":"6698","key":"10.1016\/j.molmet.2021.101217_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/25931","article-title":"Ligand binding and co-activator assembly of the peroxisome proliferator-activated receptor-gamma","volume":"395","author":"Nolte","year":"1998","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.molmet.2021.101217_bib49","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0022-2275(20)42003-6","article-title":"Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression","volume":"37","author":"Schoonjans","year":"1996","journal-title":"The Journal of Lipid Research"},{"issue":"12","key":"10.1016\/j.molmet.2021.101217_bib50","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.bbamcr.2006.09.006","article-title":"Peroxisomes and oxidative stress","volume":"1763","author":"Schrader","year":"2006","journal-title":"Biochimica et Biophysica Acta"},{"key":"10.1016\/j.molmet.2021.101217_bib51","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/srep01035","article-title":"Discovery of highly potent acid ceramidase inhibitors with in\u00a0vitro tumor chemosensitizing activity","volume":"3","author":"Realini","year":"2013","journal-title":"Scientific Reports"},{"issue":"3","key":"10.1016\/j.molmet.2021.101217_bib52","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"issue":"9","key":"10.1016\/j.molmet.2021.101217_bib53","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.3390\/ijms19092527","article-title":"Ceramide metabolism balance, a multifaceted factor in critical steps of breast cancer development","volume":"19","author":"Garcia-Gonzalez","year":"2018","journal-title":"International Journal of Molecular Sciences"},{"issue":"2","key":"10.1016\/j.molmet.2021.101217_bib54","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.canlet.2003.08.034","article-title":"Ceramide synthesis and metabolism as a target for cancer therapy","volume":"206","author":"Reynolds","year":"2004","journal-title":"Cancer Letters"},{"issue":"1","key":"10.1016\/j.molmet.2021.101217_bib55","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/s41467-018-03844-2","article-title":"Structural basis for the activation of acid ceramidase","volume":"9","author":"Gebai","year":"2018","journal-title":"Nature Communications"},{"issue":"10","key":"10.1016\/j.molmet.2021.101217_bib56","doi-asserted-by":"crossref","first-page":"4344","DOI":"10.1172\/JCI64791","article-title":"Radiation-induced acid ceramidase confers prostate cancer resistance and tumor relapse","volume":"123","author":"Cheng","year":"2013","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/j.molmet.2021.101217_bib57","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s10549-011-1768-8","article-title":"C6-ceramide and targeted inhibition of acid ceramidase induce synergistic decreases in breast cancer cell growth","volume":"133","author":"Flowers","year":"2012","journal-title":"Breast Cancer Res Treat"},{"issue":"6","key":"10.1016\/j.molmet.2021.101217_bib58","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1194\/jlr.M091876","article-title":"Acid ceramidase promotes drug resistance in acute myeloid leukemia through NF-kappaB-dependent P-glycoprotein upregulation","volume":"60","author":"Tan","year":"2019","journal-title":"The Journal of Lipid Research"},{"issue":"4","key":"10.1016\/j.molmet.2021.101217_bib59","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.3892\/or.2017.5855","article-title":"Acid ceramidase confers radioresistance to glioblastoma cells","volume":"38","author":"Doan","year":"2017","journal-title":"Oncology Reports"},{"issue":"2\u20133","key":"10.1016\/j.molmet.2021.101217_bib60","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1388-1981(02)00331-1","article-title":"Ceramide in apoptosis: an overview and current perspectives","volume":"1585","author":"Pettus","year":"2002","journal-title":"Biochimica et Biophysica Acta"},{"issue":"25","key":"10.1016\/j.molmet.2021.101217_bib61","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1038\/sj.onc.1205497","article-title":"Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells","volume":"21","author":"von Haefen","year":"2002","journal-title":"Oncogene"},{"issue":"45","key":"10.1016\/j.molmet.2021.101217_bib62","doi-asserted-by":"crossref","first-page":"17402","DOI":"10.1073\/pnas.0802781105","article-title":"Ceramide starves cells to death by downregulating nutrient transporter proteins","volume":"105","author":"Guenther","year":"2008","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"12","key":"10.1016\/j.molmet.2021.101217_bib63","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.bbamcr.2006.08.034","article-title":"Peroxisomal beta-oxidation--a metabolic pathway with multiple functions","volume":"1763","author":"Poirier","year":"2006","journal-title":"Biochimica et Biophysica Acta"},{"issue":"3","key":"10.1016\/j.molmet.2021.101217_bib64","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1432-1033.2003.03946.x","article-title":"Acyl-CoA dehydrogenases. A mechanistic overview","volume":"271","author":"Ghisla","year":"2004","journal-title":"European Journal of Biochemistry"},{"key":"10.1016\/j.molmet.2021.101217_bib65","first-page":"83","article-title":"Metabolic interplay between peroxisomes and other subcellular organelles including mitochondria and the endoplasmic reticulum","volume":"3","author":"Wanders","year":"2015","journal-title":"Frontiers in Cell and Developmental Biology"},{"issue":"14","key":"10.1016\/j.molmet.2021.101217_bib66","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.cub.2010.05.066","article-title":"Vps35 mediates vesicle transport between the mitochondria and peroxisomes","volume":"20","author":"Braschi","year":"2010","journal-title":"Current Biology"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821000612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877821000612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:26:28Z","timestamp":1761956788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877821000612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":66,"alternative-id":["S2212877821000612"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101217","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"N-acylsphingosine amidohydrolase 1 promotes melanoma growth and metastasis by suppressing peroxisome biogenesis-induced ROS production","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2021.101217","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"101217"}}